Clinical Trial Update: Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating chemotherapy plus Endostatin for advanced pancreatic neuroendocrine tumors has completed, according to ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• Endostatin (endostatin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Advanced Well-differentiated Pancreatic Neuroendocrine Tumor | Phase 2 | Status: COMPLETED